Thyroid Disorder Market Analysis by Disorder Type

1
Thyroid Disorder Market Growth to be Propelled by
the Increase in the Incidence of Thyroid
Disorders with a CAGR of 5 During
2022-2031 Kenneth Research published a report
titled Thyroid Disorder Market Global Supply
Demand Analysis Opportunity Outlook 2031 which
delivers a detailed overview of the global
thyroid disorder market in terms of market
segmentation by disorder type, by treatment
type, by route of administration, by end-user and
by region. Further, for an in-depth analysis,
the report encompasses the industry growth
indicators, restraints, supply and demand risk,
along with a detailed discussion of the current
and future market trends that are associated with
the growth of the market.
The global thyroid disorder market is predicted
to attain a revenue of nearly USD 2.6 billion by
the end of 2031 by growing at a CAGR of 5 over
the forecast period, i.e., 2022 2031. This
growth can be attributed to an increase in the
number of people affected by various thyroid
gland disorders. For instance, about 12,000 men
and 33,000 women get thyroid cancer in the
United States alone, every year, according to the
Centers for Disease Control and Prevention (CDC).
2
The global thyroid disorder market is segmented
by disorder type into hypothyroidism and
hyperthyroidism. Of these, the hypothyroidism
segment is projected to hold the highest market
share during the forecast period as it is the
most commonly occurring disorder of the thyroid
gland. Around 5 out of 100 Americans aged 12
years and older have hypothyroidism, according
to the National Institute of Diabetes and
Digestive and Kidney Diseases. For Detailed
Description_at_https//www.kennethresearch.com/report
-details/thyroid- disorder-market/10352405 North
America is projected to hold the largest market
share during the forecast period because of
advanced healthcare in the region. A high
incidence of autoimmune thyroid disorders such
as Graves disease and Hashimotos disease is
also responsible for the growth of the thyroid
disorder market. According to one of the
statistical reports shared by the NIH, Graves
disease is the most common cause of
hyperthyroidism accounting for about 60 to 80
of hyperthyroid cases with an overall prevalence
of hyperthyroidism of 1.2 in the US. The market
in the region of Asia Pacific is anticipated to
witness substantial growth over the forecast
period owing to the increase in foreign direct
investments by international companies into the
region and the improving healthcare
facilities. The research is global in nature and
covers a detailed analysis of the market in North
America (U.S., Canada), Europe (U.K., Germany,
France, Italy, Spain, Hungary, Belgium,
Netherlands Luxembourg, NORDIC Finland,
Sweden, Norway, Denmark, Poland, Turkey,
Russia, Rest of Europe), Latin America (Brazil,
Mexico, Argentina, Rest of Latin America),
Asia-Pacific (China, India, Japan, South Korea,
Indonesia, Singapore, Malaysia, Australia, New
Zealand, Rest of Asia-Pacific), Middle East and
Africa (Israel, GCC Saudi Arabia, UAE, Bahrain,
Kuwait, Qatar, Oman, North Africa, South Africa,
Rest of the Middle East and Africa). In
addition, analysis comprising market size, Y-O-Y
growth opportunity analysis, market players
competitive study, investment opportunities,
demand for future outlook, etc. have also been
covered and displayed in the research report.
3
Increase in the number of patients with Iodine
Deficiencies People from many parts of the world
still do not get enough iodine through their
diet, and iodine deficiency continues to be an
important public health concern affecting
approximately 35 of the worlds population.
Iodine-deficiency disorders are capable of
jeopardizing children's mental health and their
survival. These disorders are common in people
living in iodine-deficient areas such as Africa
and Asia. A high prevalence of iodine deficiency
is predicted to inflate the size of the global
thyroid disorder market during the forecast
period. However, the side effects of some of
the drugs used for the treatment of thyroid
disorders, lack of insurance coverage for thyroid
testing in some developed countries, and the
increased availability of cheaper generic drugs
are expected to operate as key restraints to the
growth of the thyroid disorder market over the
forecast period. This report also provides the
existing competitive scenario of some of the key
players in the thyroid disorder market which
includes company profiling of AbbVie Inc., Pfizer
Inc., Merck KGaA, AstraZeneca, Lannett Company,
Inc., Amgen Inc., Sanofi, Viatris Inc.,
GlaxoSmithKline plc., Abbott Laboratories, and
others. The profiling enfolds key information of
the companies which encompasses business
overview, products and services, key financials,
and recent news and developments. On the whole,
the report depicts a detailed overview of the
global thyroid disorder market that will help
industry consultants, equipment manufacturers,
existing players searching for expansion
opportunities, new players searching for
possibilities, and other stakeholders to align
their market-centric strategies according to the
ongoing and expected trends in the
future. Request Report Sample_at_ https//www.kenneth
research.com/sample-request- 10352405 Kenneth
Research is a leading service provider for
strategic market research and consulting. We aim
to provide unbiased, unparalleled market insights
and industry
4
analysis to help industries, conglomerates, and
executives to take wise decisions for their
future marketing strategy, expansion and
investment, etc. We believe every business can
expand to its new horizon, provided the right
guidance at the right time is available through
strategic minds. Our out-of-box thinking helps
our clients to take wise decisions in order to
avoid future uncertainties. Contact for more
Info AJ Daniel Email sales_at_kennethresearch.com
U.S. Phone [phone]